1.
2.
Age-related changes in memory and effector T cells responding to influenza A/H3N2 and pandemic A/H1N1 strains in humans
by Zhou, Xin
Vaccine, 2010, Vol.29 (11), p.2169-2177
3.
The disease burden of influenza beyond respiratory illness
by Macias, Alejandro E
Vaccine, 2021-03-15, Vol.39, p.A6-A14
4.
Estimating influenza vaccine effectiveness: Evolution of methods to better understand effects of confounding in older adults
by McElhaney, Janet E
Vaccine, 2017-11-01, Vol.35 (46), p.6269-6274
5.
Granzyme B: Correlates with protection and enhanced CTL response to influenza vaccination in older adults
by McElhaney, Janet E
Vaccine, 2009, Vol.27 (18), p.2418-2425
6.
The comparative efficacy and safety of herpes zoster vaccines: A network meta-analysis
by McGirr, Ashleigh
Vaccine, 2019-05-16, Vol.37 (22), p.2896-2909
7.
8.
Clinical and immunologic predictors of influenza illness among vaccinated older adults
by Shahid, Zainab
Vaccine, 2010, Vol.28 (38), p.6145-6151
9.
Prevention of infectious diseases in older adults through immunization: the challenge of the senescent immune response
by McElhaney, Janet E
Expert review of vaccines, 2009-05-01, Vol.8 (5), p.593-606
10.
Influenza control in the 21st century: Optimizing protection of older adults
by Monto, Arnold S
Vaccine, 2009, Vol.27 (37), p.5043-5053
11.
Immunologic correlates of protection and potential role for adjuvants to improve influenza vaccines in older adults
by McElhaney, Janet E
Expert review of vaccines, 2013-07-01, Vol.12 (7), p.759-766
12.
Report of the ad-hoc consultation on aging and immunization for a future WHO research agenda on life-course immunization
by Thomas-Crusells, Judith
Vaccine, 2012, Vol.30 (42), p.6007-6012
13.
The unmet need in the elderly: Designing new influenza vaccines for older adults
by McElhaney, Janet E
Vaccine, 2005, Vol.23, p.S10-S25
14.
Influenza vaccination in the elderly: seeking new correlates of protection and improved vaccines
by McElhaney, Janet E
Aging Health, 2008-12-01, Vol.4 (6), p.603-613
15.
Standardization and validation of assays determining cellular immune responses against influenza
by Gijzen, Karlijn
Vaccine, 2010, Vol.28 (19), p.3416-3422
16.
Efficacy and Safety of Inhaled Zanamivir in the Prevention of Influenza in Community-Dwelling, High-Risk Adult and Adolescent Subjects: A 28-day, Multicenter, Randomized, Double-Bl...
by LaForce, Craig, MD
Clinical therapeutics, 2007, Vol.29 (8), p.1579-1590
17.
Comparison of single versus booster dose of influenza vaccination on humoral and cellular immune responses in older adults
by McElhaney, Janet E
Vaccine, 2005, Vol.23 (25), p.3294-3300
18.
AS03-adjuvanted versus non-adjuvanted inactivated trivalent influenza vaccine against seasonal influenza in elderly people: a phase 3 randomised trial
by McElhaney, Janet E, Prof
The Lancet infectious diseases, 2013, Vol.13 (6), p.485-496
19.
Correlates of protection: Novel generations of influenza vaccines
by Rimmelzwaan, Guus F
Vaccine, 2008, Vol.26, p.D41-D44
20.
Safety profile of the adjuvanted recombinant zoster vaccine: Pooled analysis of two large randomised phase 3 trials
by López-Fauqued, Marta
Vaccine, 2019-04-24, Vol.37 (18), p.2482-2493
